Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease

Seminars in Immunopathology

Volumn 34, Issue 6, 2012, Pages 753-770

  Machado, Fabiana S ^a   Dutra, Walderez O ^a,e,f   Esper, Lisia ^a   Gollob, Kenneth J ^b,e,f   Teixeira, Mauro M ^a   Factor, Stephen M ^c   Weiss, Louis M ^c   Nagajyothi, Fnu ^c   Tanowitz, Herbert B ^c   Garg, Nisha J ^d  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Santa Casa Hospital   (Brazil)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e SRI INTERNATIONAL   (United States)

^f National Institute of Science and Technology in Tropical Diseases   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 4; LIPOXIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; THROMBOXANE A2; VERAPAMIL;

ANTIINFLAMMATORY ACTIVITY; APICOMPLEXAN LIFE CYCLE STAGE; CARDIOMYOPATHY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CHAGAS DISEASE; CYTOKINE RESPONSE; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MEGACOLON; MENINGOENCEPHALITIS; NONHUMAN; OXIDATIVE STRESS; PARASITE IMMUNITY; PARASITE VECTOR; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI; VASCULITIS; ADAPTIVE IMMUNITY; ANIMAL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LIFE CYCLE STAGE; PATHOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; CHAGAS DISEASE; HUMANS; IMMUNITY, INNATE; LIFE CYCLE STAGES; TRYPANOSOMA CRUZI;

EID: 84876058124     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-012-0351-7     Document Type: Review

References (174)

1. Aufderheide AC, Salo W, Madden M, Streitz J, Buikstra J, et al. (2004) A 9,000-year record of Chagas' disease. Proc Natl Acad Sci USA 101:2034-2039
2. Araujo A, Jansen AM, Reinhard K, Ferreira LF (2009) Paleoparasitology of Chagas disease - a review. Mem Inst Oswaldo Cruz 104(Suppl 1):9-16
3. Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, et al. (2012) The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 52:1922-1930
4. Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49:e52-e54
5. Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, et al. (2011) Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill 16
6. Tanowitz HB, Weiss LM, Montgomery SP (2011) Chagas disease has now gone global. PLoS Negl Trop Dis 5:e1136
7. Caradonna KL, Burleigh BA (2011) Mechanisms of host cell invasion by Trypanosoma cruzi. Adv Parasitol 76:33-61
8. Nagajyothi F, Weiss LM, Silver DL, Desruisseaux MS, Scherer PE, et al. (2011) Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis 5:e953
9. Shikanai-Yasuda MA, Carvalho NB (2012) Oral transmission of chagas disease. Clin Infect Dis 54:845-852
10. Hoff R, Teixeira RS, Carvalho JS, Mott KE (1978) Trypanosoma cruzi in the cerebrospinal fluid during the acute stage of Chagas' disease. N Engl J Med 298:604-606
11. Carod-Artal FJ, Vargas AP, Falcao T (2011) Stroke in asymptomatic Trypanosoma cruzi-infected patients. Cerebrovasc Dis 31:24-28
12. Fiorelli AI, Santos RH, Oliveira JL Jr, Lourenco-Filho DD, Dias RR, et al. (2011) Heart transplantation in 107 cases of Chagas' disease. Transplant Proc 43:220-224
13. Gutierrez FR, Lalu MM, Mariano FS, Milanezi CM, Cena J, et al. (2008) Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis 197:1468-1476
14. Andrade LO, Machado CR, Chiari E, Pena SD, Macedo AM (1999) Differential tissue distribution of diverse clones of Trypanosoma cruzi in infected mice. Mol Biochem Parasitol 100:163-172
15. dos Santos DM, Talvani A, Guedes PM, Machado-Coelho GL, de Lana M, et al. (2009) Trypanosoma cruzi: genetic diversity influences the profile of immunoglobulins during experimental infection. Exp Parasitol 121:8-14
16. Vago AR, Andrade LO, Leite AA, d'Avila Reis D, Macedo AM, et al. (2000) Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol 156:1805-1809
17. Factor SM, Sonnenblick EH (1985) The pathogenesis of clinical and experimental congestive cardiomyopathies: recent concepts. Prog Cardiovasc Dis 27:395-420
18. Factor SM, Cho SH, Scheuer J, Sonnenblick EH, Malhotra A (1988) Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy. J Am Coll Cardiol 12:1599-1604
19. Sonnenblick EH, Fein F, Capasso JM, Factor SM (1985) Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. Am J Cardiol 55:179B-184B
20. Factor SM, Cho S, Wittner M, Tanowitz H (1985) Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am J Trop Med Hyg 34:246-253
21. Tanowitz HB, Kaul DK, Chen B, Morris SA, Factor SM, et al. (1996) Compromised microcirculation in acute murine Trypanosoma cruzi infection. J Parasitol 82:124-130
22. Chandra M, Shirani J, Shtutin V, Weiss LM, Factor SM, et al. (2002) Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil strain): an echocardiographic study. Int J Parasitol 32:207-215
23. De Souza AP, Tanowitz HB, Chandra M, Shtutin V, Weiss LM, et al. (2004) Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol Res 92:496-501
24. Petkova SB, Tanowitz HB, Magazine HI, Factor SM, Chan J, et al. (2000) Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol 9:257-265
25. Jelicks LA, Chandra M, Shirani J, Shtutin V, Tang B, et al. (2002) Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol 32:1497-1506
26. Tanowitz HB, Huang H, Jelicks LA, Chandra M, Loredo ML, et al. (2005) Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 73:2496-2503
27. Hassan GS, Mukherjee S, Nagajyothi F, Weiss LM, Petkova SB, et al. (2006) Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun 74:152-159
28. Salomone OA, Caeiro TF, Madoery RJ, Amuchastegui M, Omelinauk M, et al. (2001) High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am J Cardiol 87:1217-1220, A1217
29. Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, et al. (2011) Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One 6:e16959
30. Ashton AW, Mukherjee S, Nagajyothi FN, Huang H, Braunstein VL, et al. (2007) Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204:929-940
31. Tanowitz HB, Burns ER, Sinha AK, Kahn NN, Morris SA, et al. (1990) Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am J Trop Med Hyg 43:274-281
32. Bern C, Martin DL, Gilman RH (2011) Acute and congenital Chagas disease. Adv Parasitol 75:19-47
33. Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, et al. (2009) Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis 9:324-330
34. da Silva AA, Pereira GV, de Souza AS, Silva RR, Rocha MS, et al. (2010) Trypanosoma cruzi-induced central nervous system alterations: from entry of inflammatory cells to potential cognitive and psychiatric abnormalities. J Neuroparasitol 1. Article ID N100901
35. Tanowitz HB, Brosnan C, Guastamacchio D, Baron G, Raventos-Suarez C, et al. (1982) Infection of organotypic cultures of spinal cord and dorsal root ganglia with Trypanosoma cruzi. Am J Trop Med Hyg 31:1090-1097
36. da Silveira AB, de Araujo FF, Freitas MA, Gomes JA, Chaves AT, et al. (2009) Characterization of the presence and distribution of Foxp3(+) cells in chagasic patients with and without megacolon. Hum Immunol 70:65-67
37. Chuenkova MV, Pereiraperrin M (2010) Trypanosoma cruzi-derived neurotrophic factor: role in neural repair and neuroprotection. J Neuroparasitol 1:55-60
38. Chuenkova MV, PereiraPerrin M (2005) A synthetic peptide modeled on PDNF, Chagas' disease parasite neurotrophic factor, promotes survival and differentiation of neuronal cells through TrkA receptor. Biochemistry 44:15685-15694
39. DA Silva Manoel-Caetano F, Silveira AF, Silva AE (29) Gene mutations in esophageal mucosa of chagas disease patients. Anticancer Res 29:1243-1247
40. Shoemaker JP, Hoffman RV Jr (1974) Trypanosoma cruzi: possible stimulatory factor(s) on brown adipose tissue of mice. Exp Parasitol 35:272-274
41. Shoemaker JP, Hoffman RV Jr, Huffman DG (1970) Trypanosoma cruzi: preference for brown adipose tissue in mice by the Tulahuen strain. Exp Parasitol 27:403-407
42. Andrade ZA, Silva HR (1995) Parasitism of adipocytes by Trypanosoma cruzi. Mem Inst Oswaldo Cruz 90:521-522
43. Combs TP, Nagajyothi MS, de Almeida CJ, Jelicks LA, et al. (2005) The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 280:24085-24094
44. Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, et al. (2005) Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 11:797-803
45. Nagajyothi F, Machado FS, Burleigh BA, Jelicks LA, Scherer PE, et al. (2012) Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cell Microbiol 14:634-43
46. Shetty S, Kusminski CM, Scherer PE (2009) Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 30:234-239
47. Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, et al. (2010) Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 120:3466-3479
48. Ferreira AV, Segatto M, Menezes Z, Macedo AM, Gelape C, et al. (2011) Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease. Microbes Infect 13:1002-1005
49. Nagajyothi F, Desruisseaux MS, Thiruvur N, Weiss LM, Braunstein VL, et al. (2008) Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity (Silver Spring) 16:1992-1997
50. Krautz GM, Kissinger JC, Krettli AU (2000) The targets of the lytic antibody response against Trypanosoma cruzi. Parasitol Today 16:31-34
51. Tarleton RL (2007) Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 19:430-434
52. Padilla AM, Bustamante JM, Tarleton RL (2009) CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 21:385-390
53. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449:819-826
54. Yamamoto M, Takeda K (2010) Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract 2010:240365
55. Huang H, Calderon TM, Berman JW, Braunstein VL, Weiss LM, et al. (1999) Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun 67:5434-5440
56. Machado FS, Tyler KM, Brant F, Esper L, Teixeira MM, et al. (2012) Pathogenesis of Chagas disease: time to move on. Front Biosci (Elite Ed) 4:1743-1758
57. Machado FS, Souto JT, Rossi MA, Esper L, Tanowitz HB, et al. (2008) Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 10:1558-1566
58. Coelho PS, Klein A, Talvani A, Coutinho SF, Takeuchi O, et al. (2002) Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-gamma-primed-macrophages. J Leukoc Biol 71:837-844
59. Schmitz V, Svensjo E, Serra RR, Teixeira MM, Scharfstein J (2009) Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll-like 2 receptors. J Leukoc Biol 85:1005-1014
60. Camargo MM, Almedia IC, Pereira MES, Ferguson MAJ, Travassos LR, et al. (1997) Glycosylphosphatidylinositol anchored mucin like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol 158:5890-5901
61. Monteiro AC, Schmitz V, Morrot A, de Arruda LB, Nagajyothi F, et al. (2007) Bradykinin B2 receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog 3:e185
62. Monteiro AC, Schmitz V, Svensjo E, Gazzinelli RT, Almeida IC, et al. (2006) Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J Immunol 177:6325-6335
63. Kayama H, Takeda K (2010) The innate immune response to Trypanosoma cruzi infection. Microbes Infect 12:511-517
64. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, et al. (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626-1629
65. Plata F, Wietzerbin J, Pons FG, Falcoff E, Eisen H (1984) Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur J Immunol 14:930-935
66. Vespa GN, Cunha FQ, Silva JS (1994) Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 62:5177-5182
67. Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21:361-374
68. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, et al. (2000) Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102:3003-3008
69. Cardillo F, Voltarelli JC, Reed SG, Silva JS (1996) Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 64:128-134
70. Silva JS, Twardzik DR, Reed SG (1991) Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med 174:539-545
71. Reed SG (1988) In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J Immunol 140:4342-4347
72. Miller MJ, Wrightsman RA, Stryker GA, Manning JE (1997) Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function. J Immunol 158:5330-5337
73. Zacks MA, Wen JJ, Vyatkina G, Bhatia V, Garg N (2005) An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. An Acad Bras Cienc 77:695-715
74. Holscher C, Mohrs M, Dai WJ, Kohler G, Ryffel B, et al. (2000) Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun 68:4075-4083
75. Tanowitz HB, Gumprecht JP, Spurr D, Calderon TM, Ventura MC, et al. (1992) Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J Infect Dis 166:598-603
76. Saavedra E, Herrera M, Gao W, Uemura H, Pereira MA (1999) The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J Exp Med 190:1825-1836
77. Ba X, Gupta S, Davidson M, Garg NJ (2010) Trypanosoma cruzi induces ROS-PARP-1-RelA pathway for up regulation of cytokine expression in cardiomyocytes. J Biol Chem 285:11596-11606
78. Hardison JL, Kuziel WA, Manning JE, Lane TE (2006) Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi. J Infect Dis 193:1584-1588
79. Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, et al. (2006) The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74:135-143
80. Hardison JL, Wrightsman RA, Carpenter PM, Lane TE, Manning JE (2006) The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74:125-134
81. Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, et al. (1997) Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185:1959-1968
82. Teixeira MM, Gazzinelli RT, Silva JS (2002) Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 18:262-265
83. Gutierrez FR, Guedes PM, Gazzinelli RT, Silva JS (2009) The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol 31:673-685
84. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, et al. (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746-754
85. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875
86. Goulet JL, Griffiths RC, Ruiz P, Spurney RF, Pisetsky DS, et al. (1999) Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J Immunol 163:359-366
87. Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15:599-607
88. Rola-Pleszczynski M (1985) Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions. J Immunol 135:1357-1360
89. Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, et al. (2010) 5-Lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect 12:587-597
90. Esper L, Roman-Campos D, Lara A, Brant F, Castro LL, et al. (2012) Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. Am J Pathol 181:130-140
91. Cardoni RL, Antunez MI, Morales C, Nantes IR (1997) Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 56:329-334
92. Alvarez MN, Piacenza L, Irigoin F, Peluffo G, Radi R (2004) Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi. Arch Biochem Biophys 432:222-232
93. Munoz-Fernandez MA, Fernandez MA, Fresno M (1992) Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett 33:35-40
94. Melo RC, Fabrino DL, D'Avila H, Teixeira HC, Ferreira AP (2003) Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol Int 27:853-861
95. Gupta S, Dhiman M, Wen JJ, Garg NJ (2011) ROS signalling of inflammatory cytokines during Trypanosoma cruzi infection. Adv Parasitol 76:153-170
96. Alvarez MN, Peluffo G, Piacenza L, Radi R (2011) Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity. J Biol Chem 286:6627-6640
97. Piacenza L, Peluffo G, Alvarez MN, Kelly JM, Wilkinson SR, et al. (2008) Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem J 410:359-368
98. Dhiman M, Garg NJ (2011) NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease. J Pathol 225:583-596
99. Huang H, Chan J, Wittner M, Jelicks LA, Morris SA, et al. (1999) Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 31:75-88
100. Hall BS, Tam W, Sen R, Pereira ME (2000) Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection. Mol Biol Cell 11:153-160
101. Huang H, Petkova SB, Cohen AW, Bouzahzah B, Chan J, et al. (2003) Activation of transcription factors AP-1 and NF-kappa B in murine chagasic myocarditis. Infect Immun 71:2859-2867
102. Gupta S, Bhatia V, Wen J-J, Wu Y, Huang M-H, et al. (2009) Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes. Free Radic Biol Med 47:1414-1421
103. Balakumar P, Singh M (2006) Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy. Methods Find Exp Clin Pharmacol 28:683-689
104. Pacher P, Szabo C (2008) Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173:2-13
105. Wen J-J, Vyatkina G, Garg N (2004) Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic Biol Med 37:1821-1833
106. Perez-Fuentes R, Guegan JF, Barnabe C, Lopez-Colombo A, Salgado-Rosas H, et al. (2003) Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int J Parasitol 33:293-299
107. de Oliveira TB, Pedrosa RC, Filho DW (2007) Oxidative stress in chronic cardiopathy associated with Chagas disease. Int J Cardiol 116:357-363
108. Wen J-J, Bhatia V, Popov VL, Garg NJ (2006) Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas disease. Am J Pathol 169:1953-1964
109. Wen J-J, Yachelini PC, Sembaj A, Manzur RE, Garg N (2006) Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radic Biol Med 41:270-276
110. Wen J-J, Gupta S, Guan Z, Dhiman M, Condon D, et al. (2010) Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats. J Am Coll Cardiol 55:2499-2508
111. Macao LB, Filho DW, Pedrosa RC, Pereira A, Backes P, et al. (2007) Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease. Int J Cardiol 123:43-9
112. Liaudet L, Vassalli G, Pacher P (2009) Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front Biosci 14:4809-4814
113. Xiao L, Pimental DR, Amin JK, Singh K, Sawyer DB, et al. (2001) MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33:779-787
114. Kuster GM, Pimentel DR, Adachi T, Ido Y, Brenner DA, et al. (2005) Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 111:1192-1198
115. Satoh S, Tanaka H, Ueda Y, Oyama J, Sugano M, et al. (2007) Transient receptor potential (TRP) protein 7 acts as a G protein-activated Ca2+ channel mediating angiotensin II-induced myocardial apoptosis. Mol Cell Biochem 294:205-215
116. Dingar D, Merlen C, Grandy S, Gillis MA, Villeneuve LR, et al. (2010) Effect of pressure overload-induced hypertrophy on the expression and localization of p38 MAP kinase isoforms in the mouse heart. Cell Signal 22:1634-1644
117. Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, et al. (2006) Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 103:7432-7437
118. Pan J, Chang Q, Wang X, Son Y, Zhang Z, et al. (2010) Reactive oxygen species-activated Akt/ASK1/p38 signaling pathway in nickel compound-induced apoptosis in BEAS 2B cells. Chem Res Toxicol 23:568-577
119. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, et al. (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98:794-799
120. Tanaka K, Honda M, Takabatake T (2001) Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 37:676-685
121. Bouzahzah B, Yurchenko V, Nagajyothi F, Hulit J, Sadofsky M, et al. (2008) Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts. Cell Cycle 7:500-503
122. Huang YF, Gong KZ, Zhang ZG (2003) Different roles of ERK(1/2) and p38 MAPK(alpha/beta) in cellular signaling during cardiomyocyte anoxia preconditioning. Sheng Li Xue Bao 55:454-458
123. Adesse D, Lisanti MP, Spray DC, Machado FS, Meirelles Mde N, et al. (2010) Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart. Cell Cycle 9:1639-1646
124. Nagajyothi F, Desruisseaux M, Bouzahzah B, Weiss LM, Andrade Ddos S, et al. (2006) Cyclin and caveolin expression in an acute model of murine chagasic myocarditis. Cell Cycle 5:107-112
125. Hulit J, Bash T, Fu M, Galbiati F, Albanese C, et al. (2000) The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem 275:21203-21209
126. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, et al. (2003) Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 284:C457-C474
127. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, et al. (2002) Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277:38988-38997
128. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, et al. (2002) Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 160:2207-2217
129. Gullestad L, Aukrust P (2005) Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am J Cardiol 95:17C-23C, Discussion, 38C-40C
130. Cunha-Neto E, Rizzo LV, Albuquerque F, Abel L, Guilherme L, et al. (1998) Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res 31:133-137
131. Krettli AU, Brener Z (1982) Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. J Immunol 128:2009-2012
132. Gazzinelli RT, Pereira ME, Romanha A, Gazzinelli G, Brener Z (1991) Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunol 13:345-356
133. Grauert MR, Houdayer M, Hontebeyrie-Joskowciz M (1993) Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease. Clin Exp Immunol 93:85-92
134. Teixeira AR, Teixeira G, Macedo V, Prata A (1978) Acquired cell-mediated immunodepression in acute Chagas' disease. J Clin Invest 62:1132-1141
135. Antas PR, Medrano-Mercado N, Torrico F, Ugarte-Fernandez R, Gomez F, et al. (1999) Early, intermediate, and late acute stages in Chagas' disease: a study combining anti-galactose IgG, specific serodiagnosis, and polymerase chain reaction analysis. Am J Trop Med Hyg 61:308-314
136. Cordeiro FD, Martins-Filho OA, Da Costa Rocha MO, Adad SJ, Correa-Oliveira R, et al. (2001) Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin Diagn Lab Immunol 8:112-118
137. Galvao LM, Nunes RM, Cancado JR, Brener Z, Krettli AU (1993) Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study. Trans R Soc Trop Med Hyg 87:220-223
138. Cunha-Neto E, Duranti M, Gruber A, Zingales B, De Messias I, et al. (1995) Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA 92:3541-3545
139. Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, et al. (2006) Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease. Microbes Infect 8:2459-2464
140. Cunha-Neto E, Teixeira PC, Fonseca SG, Bilate AM, Kalil J (2011) Myocardial gene and protein expression profiles after autoimmune injury in Chagas' disease cardiomyopathy. Autoimmun Rev 10:163-165
141. Dhiman M, Zago MP, Nunez S, Nunez-Burgio F, Garg NJ (2012) Cardiac oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in Chagas disease pathogenesis. PLoS ONE 7:e28449
142. Reis DD, Gazzinelli RT, Gazzinelli G, Colley DG (1993) Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease. J Immunol 150:1611-1618
143. Gazzinelli RT, Leme VM, Cancado JR, Gazzinelli G, Scharfstein J (1990) Identification and partial characterization of Trypanosoma cruzi antigens recognized by T cells and immune sera from patients with Chagas' disease. Infect Immun 58:1437-1444
144. Gazzinelli RT, Leme VM, Cancado JR, Gazzinelli G, Scharfstein J (1988) Identification of Trypanosoma cruzi antigens recognized by T cells and immune sera from chagasic patients. Mem Inst Oswaldo Cruz 83(Suppl 1):272-279
145. Dutra WO, Colley DG, Pinto-Dias JC, Gazzinelli G, Brener Z, et al. (2000) Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol 51:91-97
146. el Cheikh MC, Hontebeyrie-Joskowicz M, Coutinho A, Minoprio P (1992) CD5 B cells. Potential role in the (auto)immune responses to Trypanosoma cruzi infection. Ann N Y Acad Sci 651:557-563
147. Sathler-Avelar R, Lemos EM, Reis DD, Medrano-Mercado N, Araujo-Jorge TC, et al. (2003) Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand J Immunol 58:655-663
148. King IL, Fortier A, Tighe M, Dibble J, Watts GF, et al. (2012) Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol 13:44-50
149. Kierszenbaum F, Cuna WR, Beltz LA, Sztein MB (1990) Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells. J Immunol 144:4000-4004
150. Costa RP, Gollob KJ, Fonseca LL, Rocha MO, Chaves AC, et al. (2000) T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand J Immunol 51:511-519
151. Menezes CA, Rocha MO, Souza PE, Chaves AC, Gollob KJ, et al. (2004) Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol 137:129-138
152. Fuenmayor C, Higuchi ML, Carrasco H, Parada H, Gutierrez P, et al. (2005) Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. Acta Cardiol 60:33-37
153. Tarleton RL (1990) Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J Immunol 144:717-724
154. Mosca W, Briceno L, Hernandez MI (1991) Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells. Mem Inst Oswaldo Cruz 86:147-152
155. Morato MJ, Brener Z, Cancado JR, Nunes RM, Chiari E, et al. (1986) Cellular immune responses of chagasic patients to antigens derived from different Trypanosoma cruzi strains and clones. Am J Trop Med Hyg 35:505-511
156. Dutra WO, da Luz ZM, Cancado JR, Pereira ME, Brigido-Nunes RM, et al. (1996) Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy. Parasite Immunol 18:579-585
157. Dutra WO, Martins-Filho OA, Cancado JR, Pinto-Dias JC, Brener Z, et al. (1994) Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol 6:499-506
158. Reis DD, Jones EM, Tostes S Jr, Lopes ER, Gazzinelli G, et al. (1993) Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 48:637-644
159. Reis DD, Jones EM, Tostes S, Lopes ER, Chapadeiro E, et al. (1993) Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am J Trop Med Hyg 49:192-200
160. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, et al. (2005) Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73:7960-7966
161. Talvani A, Rocha MO, Cogan J, Maewal P, de Lemos J, et al. (2004) Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem Inst Oswaldo Cruz 99:645-649
162. Dutra WO, Menezes CA, Villani FN, da Costa GC, da Silveira AB, et al. (2009) Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz 104(Suppl 1):208-218
163. Higuchi MD, Benvenuti LA, Martins Reis M, Metzger M (2003) Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60:96-107
164. Albareda MC, Laucella SA, Alvarez MG, Armenti AH, Bertochi G, et al. (2006) Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol 18:465-471
165. Souza PE, Rocha MO, Menezes CA, Coelho JS, Chaves AC, et al. (2007) Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease. Infect Immun 75:1886-1894
166. Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, et al. (2004) Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 72:5283-5291
167. Cuellar A, Santander SP, Thomas Mdel C, Guzman F, Gomez A, et al. (2008) Monocyte-derived dendritic cells from chagasic patients vs healthy donors secrete differential levels of IL-10 and IL-12 when stimulated with a protein fragment of Trypanosoma cruzi heat-shock protein-70. Immunol Cell Biol 86:255-260
168. Dutra WO, Gollob KJ, Pinto-Dias JC, Gazzinelli G, Correa-Oliveira R, et al. (1997) Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol 45:74-80
169. Benvenuti LA, Higuchi ML, Reis MM (2000) Upregulation of adhesion molecules and class I HLA in the myocardium of chronic chagasic cardiomyopathy and heart allograft rejection, but not in dilated cardiomyopathy. Cardiovasc Pathol 9:111-117
170. Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, et al. (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 167:305-313
171. Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, et al. (2007) Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci 12:2797-2806
172. Villani FN, Rocha MO, Nunes Mdo C, Antonelli LR, Magalhaes LM, et al. (2010) Trypanosoma cruzi-induced activation of functionally distinct alphabeta and gammadelta CD4- CD8- T cells in individuals with polar forms of Chagas' disease. Infect Immun 78:4421-4430
173. Dutra WO, Gollob KJ (2008) Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 21:287-292
174. Drigo SA, Cunha-Neto E, Ianni B, Cardoso MR, Braga PE, et al. (2006) TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 8:598-603